The impact of clinical trials on the treatment of diabetes mellitus

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 5, 2002, Pages 1929-1937

  Nathan, David M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CAPTOPRIL; CREATININE; GLUCOSE; INSULIN; SULFONYLUREA;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES CONTROL; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; LASER COAGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; SECONDARY PREVENTION; DIABETES MELLITUS; MASS COMMUNICATION;

CLINICAL TRIALS; DIABETES MELLITUS; DIFFUSION OF INNOVATION; HUMANS;

EID: 85047686385     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.5.7640     Document Type: Review

References (74)

1. Streptomycin treatment of pulmonary tuberculosis
2. Unbiased, relevant and reliable assessments in health care: Important progress during the past century, but plenty of scope for doing better
3. Randomized, controlled trials, observational studies, and the hierarchy of research designs
4. A comparison of observational studies and randomized, controlled trials
5. Vitamin E supplementation and cardiovascular events in high risk patients
6. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas
7. The antioxidant vitamins and cardiovascular disease
8. Intake of fat, meat, and fiber in relation to risk of colon cancer in men
9. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults
10. The high prevalence of diabetes mellitus, impaired glucose tolerance and diabetic retinopathy in Nauru
11. Risk factors for non-insulin dependent diabetes
12. Long-term complications of diabetes mellitus
13. Pancreatic extracts in the treatment of diabetes mellitus. Preliminary report
14. Avoidance of degenerative lesions in diabetes mellitus
15. Clinical evaluation of vascular damage in diabetes mellitus
16. "Control" and diabetes
17. Control of blood glucose and diabetic vascular disease
18. Tests of glycemia in diabetes mellitus
19. The clinical information value of the glycosylated hemoglobin assay
20. The modern management of insulin-dependent diabetes mellitus
21. The effect of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus: The Diabetes Control and Complications Trial
22. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus
23. Hypoglycemia in the Diabetes Control and Complications Trial
24. The association between glycemic exposure and long-term diabetic complications in the Diabetes Control and Complications Trial
25. Pregnancy outcomes in the Diabetes Control and Complications Trial
26. Effect of pregnancy on microvascular complications in the Diabetes Control and Complications Trial
27. Effect of intensive therapy on residual B-cell function in patients with type 1 diabetes in the Diabetes Control and Complications Trial
28. Lifetime benefits of intensive therapy as practiced in the Diabetes Control and Complications Trial
29. Position statement: Implications of the Diabetes Control and Complications Trial
30. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy
31. Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: Incidence and risk factors
32. The association of hemoglobin A1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study
33. Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial
34. Glycemic control in diabetes mellitus: Have changes in therapy made a difference?
35. Le diabete avant le decouverture de l'insuline
36. A study of the effects of hypoglycemic agents on vascular complications in patients with adult onset diabetes. II. Mortality results
37. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
38. Some answers, more controversy, from UKPDS
39. Preliminary report on effects of photocoagulation therapy
40. Results from the Early Treatment Diabetic Retinopathy Study
41. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy
42. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
43. Preserving renal function in adults with hypertension and diabetes: A consensus report
44. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria
45. Use of Enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus
46. Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria
47. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus
48. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
49. Declining incidence of nephropathy in insulin-dependent diabetes mellitus
50. Unchanged incidence of diabetic nephropathy in IDDM patients
51. Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus
52. The effect of dietary protein restriction on the progression of diabetic and non-diabetic renal disease: A meta-analysis
53. The effect of intensive diabetes therapy on the development and progression of neuropathy
54. Limited benefit of treatment of diabetic polyneuopathy with an aldose reductase inhibitor: A 24 week controlled trial
55. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy
56. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus
57. Sidenafil for treatment of erectile dysfunction in men with diabetes: A randomized controlled trial
58. Prospective randomized study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus
59. Effect of diuretic based antihypertensive treatment on cardiovascular disease risk in older patients with isolated systolic hypertension
60. Cardiovascular events and their reduction with pravastatin in diabetic and glucose intolerant myocardial infarction survivors with average cholesterol levels
61. Cholesterol lowering with simvistatin improves prognosis of diabetic patients with coronary heart disease
62. Genfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
63. Aspirin effects on morbidity and mortality in patients with diabetes mellitus
64. Final report of the aspirin component of the ongoing Physicians Health Study
65. Double-blind controlled trial of azathioprine in children with newly diagnosed type 1 diabetes
66. Cyclosporin-induced remission of IDDM after early intervention
67. The Diabetes Prevention Trial-Type 1 Diabetes (DPT-1): Implementation of screening and staging of relatives
68. Practice of nicotinamide trials in pre-type 1 diabetes
69. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The DaQing IGT and Diabetes Study
70. Type 2 diabetes can be prevented by lifestyle intervention: The final results from the randomized Finnish Diabetes Prevention Study (DPS)
71. The diabetes prevention program
72. Photocoagulation treatment of proliferation diabetic retinopathy
73. Photocoagulation for diabetic macular edema